CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...